Products Categories
CAS No.: | 79547-78-7 |
---|---|
Name: | LEVOCABASTINE HYDROCHLORIDE |
Molecular Structure: | |
Formula: | C26H29 F N2 O2 . Cl H |
Molecular Weight: | 457.03 |
Synonyms: | 4-Piperidinecarboxylicacid, 1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-,monohydrochloride, [3S-[1(cis),3a,4b]]-; 4-Piperidinecarboxylic acid,1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-,monohydrochloride, (3S,4R)- (9CI); Levocabastine hydrochloride; Livostin |
Boiling Point: | 611oC at 760 mmHg |
Flash Point: | 323.3oC |
Hazard Symbols: | Moderately toxic by ingestion. |
Risk Codes: | 36/37/38 |
Safety: | Moderately toxic by ingestion. When heated to decomposition it emits toxic vapors of NOx, HCl, and Cl−. |
PSA: | 64.33000 |
LogP: | 5.63398 |
What can I do for you?
Get Best Price
IUPAC Name: (3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride
Synonyms: (3S,4R)-1-(cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid monohydrochloride ; (3S,4R)-1-[cis-4-Cyan-4-(4-fluorphenyl)cyclohexyl]-3-methyl-4-phenylpiperidin-4-carbonsäurehydrochlorid ; (3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride ; (3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride (1:1)
CAS NO: 79547-78-7
Molecular Formula of Levocabastine hydrochloride (CAS NO.79547-78-7) : C26H30ClFN2O2
Molecular Weight of Levocabastine hydrochloride (CAS NO.79547-78-7) : 456.98
Molecular Structure of Levocabastine hydrochloride (CAS NO.79547-78-7) :
Mol File: 79547-78-7.mol
Flash Point: 323.3 °C
Enthalpy of Vaporization: 95.39 kJ/mol
Boiling Point: 611 °C at 760 mmHg
Vapour Pressure: 8.77E-16 mmHg at 25°C
Solubility DMSO: ~10 mg/mL, soluble
Appearance:color white solid
Solubility: in water, slightly soluble in ethanol, insoluble in chloroform or ether; in soluble in dilute acid.
Levocabastine hydrochloride (CAS NO.79547-78-7) is used for treatment with liver coma and paralysis agitans.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | oral | 2560mg/kg (2560mg/kg) | CARDIAC: OTHER CHANGES BLOOD: HEMORRHAGE | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 1661, 2000. |
rat | LD50 | oral | > 2560mg/kg (2560mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 1661, 2000. |
Moderately toxic by ingestion. When heated to decomposition it emits toxic vapors of NOx, HCl, and Cl−.
Hazard Codes Xi
Risk Statements 36/37/38
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36:Wear suitable protective clothing.
WGK Germany 3